Skip To Main Content

Our Infectious Disease Portfolio

Find product and prescribing information, as well as other resources, for Genentech’s infectious disease portfolio below.

C

CellCept®

(mycophenolate mofetil)

Prescribing Information
Medication Guide

Safety Data Sheets:

CELLCEPT® Capsules (250 mg)
CELLCEPT® Film Coated Tablets (500 mg)
CELLCEPT® Lyophilized Vials (500 mg)
CELLCEPT® Powder for Oral Suspension
CELLCEPT® Oral Suspension

Healthcare Provider Letters:

Correction of labeling provided with CellCept® Intravenous and CellCept® Oral Suspension - May 2015
Important Changes in the CellCept® Prescribing Information - June 2008
Mycophenolate REMS (Risk Evaluation and Mitigation Strategy) - 2012
Reports of Pure Red Cell Aplasia - Aug 2009
Pregnancy Notice - 2010
Pharmacists: Important New Dispensing Information - Jan 2009
Introduction of a CellCept Medication Guide - Jan 2009
Important Changes in the CellCept® Prescribing Information - Oct 2007

F

Fuzeon®

(enfuvirtide)

Prescribing Information
Important Patient Information

Safety Data Sheets:

FUZEON® Lyophilized Vials (90 mg)

T

Tamiflu®

(oseltamivir phosphate)

Prescribing Information
Important Patient Information

Safety Data Sheets:

TAMIFLU® Capsules (30 mg)
TAMIFLU® Capsules (45 mg)
TAMIFLU® Capsules (75 mg)
TAMIFLU® Suspension (6 mg/mL)
TAMIFLU® Powder for Oral Suspension (30 mg/5 mL)

Healthcare Provider Letters:

Tamiflu Dear Pharmacist Letter Removal of Dosing Dispenser - Aug 2013
Important Prescribing Information for Patients Under 1 - Jan 2013

V

Valcyte®

(valgancyclovir hydrochloride)

Prescribing Information
Important Patient Information

Safety Data Sheets:

VALCYTE® Powder for Oral Solution (50 mg/mL)
VALCYTE® F.C. Tablets (450 mg)

Healthcare Provider Letter:

Important Prescribing Information - July 2021

X

Xofluza®

(baloxavir marboxil)

Prescribing Information
Important Patient Information

Safety Data Sheets:

XOFLUZA® Granules for Oral Suspension
XOFLUZA® Reconstituted Oral Suspension (2 mg/mL)
XOFLUZA® Tablets (40 mg)

Healthcare Provider Letter:

Important Prescribing Information - October 2019
Publications icon

Publications

Visit PubMed.gov to view scientific literature for Genentech infectious disease portfolio products.

CellCept® at PubMed.gov

Fuzeon® at PubMed.gov

Tamiflu® at PubMed.gov

Valcyte® at PubMed.gov

Xofluza® at PubMed.gov

Scientific congresses icon

Scientific Congresses

Genentech maintains a presence at in-person and virtual scientific congresses worldwide. Find Genentech-sponsored posters and presentations from recent congresses at Medically.gene.com.

Clinical trials icon

Clinical Trials

Find information about active clinical research for Genentech infectious disease portfolio products.

CellCept® at ClinicalTrials.gov

Fuzeon® at ClinicalTrials.gov

Tamiflu® at ClinicalTrials.gov

Valcyte® at ClinicalTrials.gov

Xofluza® at ClinicalTrials.gov

Additional resources icon

Additional Resources

Connect with a Medical Science Liaison

Browse the Genentech Medical Information Library